Uncategorized Archives - Page 45 of 87 - PsychedelicNewsWire (PNW)

MondayMar 01, 2021 1:45 pm

Vermont Legislators Draft Drug, Psychedelic Decriminalization Bills for 2021 Session

Legislators in Vermont are planning to introduce no fewer than two measures to decriminalize drug possession this legislative session. In an interview, State Rep. Brian Cina stated that the bill he plans to introduce would eliminate penalties imposed on a range of fungi and plant-based psychedelics, including DMT, psilocybin, ibogaine and mescaline. In a press conference, Rep. Selene Colburn stated that a bill she was working on would decriminalize all drugs was being drafted and would be introduced later in the session. Colburn stated that legislators were still working out the model, adding that they would probably use Oregon’s measure…

FridayFeb 26, 2021 12:15 pm

California State Senator Introduces Bill to Decriminalize Psychedelics

Recently, a legislator from California introduced a bill that would decriminalize psychedelics in the state, in an attempt to end the disproportionate war on drugs that has raged in the country since the 1970s. The legislator who drafted the bill, Scott Weiner, hopes that by following in the footsteps of cities that have decriminalized psychedelics, such as the District of Columbia, Santa Cruz and Oakland, the state of California will be one step closer to decriminalizing both the possession and use of all drugs, which is what the state of Oregon did when it passed a similar ballot measure during…

ThursdayFeb 25, 2021 2:45 pm

Massachusetts Legislators Introduce Bills to Study Psychedelics, Remove Criminal Penalties

Last week, legislators in Massachusetts introduced initiatives that may help end the war on drugs in the state. One measure would establish a task force whose focus will be to study fungi and plant-based psychedelics, its objective being to regulate and legalize these substances. The second other proposal would do away with criminal penalties for drug possession. This isn’t the only call to end criminal prohibition in the state. Recently, the city councils of Cambridge and Somerville adopted initiatives that made possession of psychedelics among the lowest law enforcement priorities for their municipalities. HD 3439, which was introduced to the…

ThursdayFeb 25, 2021 12:27 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Inks First CBD Oil Commercial Sale; Looks to Grow in Key Spaces

Pure Extracts is preparing to deliver shipment of 85% pure CBD distillate Company proud of quality offering produced in world-class facility PULL uses proprietary state-of-the art, sub-critical/super-critical CO2extraction system Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has signed a contract for its first CBD oil commercial sale on the wholesale market (https://ibn.fm/92kPG). Pure Extracts is preparing to deliver the first of what it anticipates will be multiple shipments this year of its 85% pure CBD distillate under this contract. “We are excited to have completed our first commercial order, and we are proud of the quality of…

WednesdayFeb 24, 2021 3:02 pm

Will the Biden Administration Embrace Federal Psychedelic Reform?

President Joe Biden’s administration and Congress is underway, and while psychedelic reform isn’t among the administration’s top priorities, advocates are hopeful that the president’s term will bring more policy changes that will gradually do away with the federal prohibition of MDMA, psilocybin and other psychedelics. In the recent past, advocates of reform have mainly been focusing on local measures. During the November 2020 election, Washington, DC, decriminalized all fungi and plant-based psychedelics while the state of Oregon decriminalized all drugs and legalized psilocybin therapy. Since then, State Representative Michael Greico of Florida has been working on a measure to legalize…

TuesdayFeb 23, 2021 12:15 pm

Researchers to Investigate Whether DMT Can Accelerate Recovery from Stroke

Algernon Pharmaceuticals, a Canadian company, plans to conduct a clinical trial to study how DMT, a psychedelic drug, can be used to trigger faster recovery in people who have had a stroke. The company says that study participants will receive a “microdose,” or an amount too small to trigger the hallucinogenic effects of the drug. While this small dose is too small for subjects to “trip,” it is hoped that the small dose will be sufficient to boost the recovery of neural activity and connections within the brain, thereby reducing how much damage the brain could suffer during and after…

MondayFeb 22, 2021 12:30 pm

How Psychedelics Are Helping Advance Modern Technology

In the 1950s, Oscar Janiger, a psychiatrist interested in LSD’s effect on creativity, dosed more than 950 individuals with the drug in his LA home. He carefully wrote down each individual’s experience and concluded at the end of his experiment that LSD could affect individuals who were already creative but could not make noncreative individuals more creative. He recognized that while LSD couldn’t inspire an individual who wasn’t creative to suddenly begin writing poetry or painting, it did provide creative individuals insights into their craft’s nature. Another researcher who was immensely interested in LSD, a chemist by the name of…

MondayFeb 22, 2021 12:17 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) Closer to Pure Mushrooms Sales with Company Code, NPN Submission

PULL recently received Company Code from Canada’s Natural and Non-prescription Health Products Directorate Code allows PULL to submit application to sell its first functional mushroom product Company intends to submit additional NPN applications during 2021 as part of larger strategy to develop portfolio of functional mushroom wellness products Functional mushrooms, those that provide a health benefit beyond just nutrition, are growing in popularity worldwide amid an accelerating trend to fend off viruses with immune-boosting food and drinks. Looking to seize part of a global functional mushroom market forecast by Data Bridge Market Research to hit $555.9 billion by 2028, Pure…

FridayFeb 19, 2021 1:15 pm

New Texas Legislation Will Allow State to Study MDMA, Psilocybin as Potential Treatments for Depression and PTSD

Last week, a legislator from Texas introduced a measure that would require the state to look into the therapeutic possibilities that ketamine, MDMA and psilocybin possess, which could help treat various mental health disorders.The bill, introduced by Rep. Alex Dominguez, would order that the Department of State Health in collaboration with the Texas Medical Board Services carry out the study and present their findings by Dec. 1, 2022. The bill, HB 1802, states that the researchers should assess and establish whether alternative therapies are successful in treating various mental health conditions such as chronic migraines and pain, bipolar disorder, post-traumatic…

ThursdayFeb 18, 2021 2:30 pm

Massachusetts General Hospital to Study How Psychedelics Influence the Brain

Massachusetts General Hospital is partnering with Atai Life Sciences to study the effects of psychedelics on the human brain. Atai Life Sciences is a biotech firm focused on developing medications to manage schizophrenia while also working on creating alternative treatments for various mental health conditions such as anxiety and depression. The two organizations decided to work together after the hospital set up a program, named the Center for Neuroscience of Psychedelics, to study psychedelic therapy. A psychiatric at the hospital, Jerrold Rosenbaum is the head of the program and has specialized in the treatment of psychiatric disorders. Rosenbaum stated that…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized